DK2641897T3 - Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamid og syntetiske mellemprodukter deraf - Google Patents

Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamid og syntetiske mellemprodukter deraf Download PDF

Info

Publication number
DK2641897T3
DK2641897T3 DK13172499.9T DK13172499T DK2641897T3 DK 2641897 T3 DK2641897 T3 DK 2641897T3 DK 13172499 T DK13172499 T DK 13172499T DK 2641897 T3 DK2641897 T3 DK 2641897T3
Authority
DK
Denmark
Prior art keywords
compound
methyl
yloxy
methoxy
formula
Prior art date
Application number
DK13172499.9T
Other languages
English (en)
Inventor
Silvano Spinelli
Valeria Livi
Original Assignee
Clovis Oncology Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clovis Oncology Italy S R L filed Critical Clovis Oncology Italy S R L
Application granted granted Critical
Publication of DK2641897T3 publication Critical patent/DK2641897T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/44Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (4)

1. Forbindelse med formel (XI) eller (Xla):
hvor R' er hydrogen og R er udvalgt blandt benzyl, acetyl, benzoyl, trifluor-methansulfonyl, benzensulfonyl, p-toluensulfonyl, methoxycarbonyl, ethoxy-carbonyl, tert-butoxycarbonyl, allyloxycarbonyl og benzyloxycarbonyl eventuelt substitueret på den aromatiske ring med op til tre substituenter udvalgt blandt halogen, cyano og trifluormethyl; eller R' er trimethylsilyl og R er tert-butoxycarbonyl; eller R og R' sammen med det nitrogenatom, de er bundet til, for at danne en phthalimidogruppe.
2. Forbindelse med formel (XII):
i hvilken X er udvalgt blandt Cl, Br eller I, og hvor R' er hydrogen og R er udvalgt blandt benzyl, acetyl, benzoyl, trifluormethansulfonyl, benzensulfonyl, p-toluensulfonyl, methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, allyloxycarbonyl og benzyloxycarbonyl eventuelt substitueret på den aromatiske ring med op til tre substituenter udvalgt blandt halogen, cyano og trifluormethyl; eller R' er trimethylsilyl og R er tert-butoxycarbonyl; eller R og R' sammen med det nitrogenatom, de er bundet til, for at danne en phthalimidogruppe.
3. Forbindelse ifølge et af kravene 1 eller 2 udvalgt blandt: 1-[(4-hydroxy-6-methoxyquinolin-7-yloxy)methyl]-N-benzyloxycarbonyl-1- aminocyclopropan; 1-[(4-chlor-6-methoxyquinolin-7-yloxy)methyl]-N-benzyloxycarbonyl-1- aminocyclopropan.
4. Anvendelse af en forbindelse ifølge krav 1-3 som et mellemprodukt i syntese af 6-(7-((1 -aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamid (I) eller et farmaceutisk acceptabelt salt deraf.
DK13172499.9T 2009-03-16 2010-03-11 Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamid og syntetiske mellemprodukter deraf DK2641897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2009A000397A IT1393351B1 (it) 2009-03-16 2009-03-16 Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi
EP10712320.0A EP2408739B1 (en) 2009-03-16 2010-03-11 A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof

Publications (1)

Publication Number Publication Date
DK2641897T3 true DK2641897T3 (da) 2016-10-03

Family

ID=41210541

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13172499.9T DK2641897T3 (da) 2009-03-16 2010-03-11 Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamid og syntetiske mellemprodukter deraf
DK10712320.0T DK2408739T3 (da) 2009-03-16 2010-03-11 Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamid og syntetiske mellemprodukter deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10712320.0T DK2408739T3 (da) 2009-03-16 2010-03-11 Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamid og syntetiske mellemprodukter deraf

Country Status (16)

Country Link
US (3) US8642767B2 (da)
EP (3) EP2641897B1 (da)
JP (2) JP5817079B2 (da)
CN (3) CN104193676B (da)
CY (2) CY1114503T1 (da)
DK (2) DK2641897T3 (da)
ES (2) ES2431618T3 (da)
HK (2) HK1167136A1 (da)
HR (2) HRP20130978T1 (da)
HU (1) HUE029528T2 (da)
IT (1) IT1393351B1 (da)
PL (2) PL2641897T3 (da)
PT (2) PT2641897T (da)
SI (2) SI2408739T1 (da)
SM (1) SMT201600356B (da)
WO (1) WO2010105761A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1393351B1 (it) 2009-03-16 2012-04-20 Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi
KR102275034B1 (ko) 2013-01-18 2021-07-12 어드밴첸 파마수티컬스, 엘엘씨 항-종양제 6-(7-((1-아미노시클로프로필)메톡시)-6-메톡시퀴놀린-4-일옥시)-n-메틸-1-나프타미드 및 그의 결정형을 제조하는 공정
CN105311029A (zh) 2014-06-06 2016-02-10 正大天晴药业集团股份有限公司 抗肿瘤活性的喹啉衍生物
CN105311030B (zh) 2014-06-06 2020-03-24 正大天晴药业集团股份有限公司 用于抗肿瘤的螺取代化合物
WO2016010869A2 (en) 2014-07-14 2016-01-21 Advenchen Pharmaceuticals, LLC FUSED QUINOLINE COMPUNDS AS PI3K, mTOR INHIBITORS
AU2015360095B2 (en) 2014-12-09 2020-02-27 Advenchen Laboratories Nanjing Ltd Quinoline derivative against non-small cell lung cancer
US9751859B2 (en) 2015-05-04 2017-09-05 Advenchen Pharmaceuticals, LLC Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
AU2016293841B2 (en) 2015-07-11 2020-10-08 Advenchen Pharmaceuticals, LLC Fused quinoline compunds as pi3k/mTor inhibitors
KR20180086187A (ko) 2015-10-05 2018-07-30 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료
CN107296811B (zh) 2016-04-15 2022-12-30 正大天晴药业集团股份有限公司 一种用于治疗胃癌的喹啉衍生物
CN109748902B (zh) * 2017-11-02 2020-11-06 杭州科巢生物科技有限公司 一种盐酸安罗替尼的制备方法
EP3766870B1 (en) 2018-03-02 2023-09-27 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Crystal of compound as c-met kinase inhibitor and preparation method therefor and use thereof
JP2021515767A (ja) 2018-03-07 2021-06-24 バイエル・アクチエンゲゼルシヤフト Erk5阻害剤の同定及び使用
CN110483392A (zh) * 2018-05-14 2019-11-22 上海海和药物研究开发有限公司 合成n-保护的喹啉-7-基氧基甲基环丙基胺衍生物的方法及合成中间体
CN110483393A (zh) * 2018-05-14 2019-11-22 上海海和药物研究开发有限公司 德立替尼的晶型
CN109705093A (zh) * 2018-12-29 2019-05-03 正大天晴药业集团股份有限公司 喹啉衍生物及其制备方法和用途
CN115160221A (zh) * 2022-07-26 2022-10-11 上海歆贻医药科技有限公司 德立替尼晶型化合物和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9714432A (pt) * 1996-12-23 2000-05-02 Hoeschst Marion Roussel Inc Derivados de 3-aril-2-(1-substituìdo-4-piperidinil)-1(1-di(oxo-3h-bezo [d]-isoatiazol, sua preparação e seu uso como moduladores de função neurotransmissora
EE05345B1 (et) * 1999-02-10 2010-10-15 Astrazeneca Ab Kinasoliini derivaadid angiogeneesi inhibiitoritena
AU2003257666A1 (en) * 2002-08-23 2004-03-11 Kirin Beer Kabushiki Kaisha COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
BRPI0418102A (pt) * 2003-12-23 2007-04-27 Pfizer derivados de quinolina
US8163923B2 (en) * 2007-03-14 2012-04-24 Advenchen Laboratories, Llc Spiro substituted compounds as angiogenesis inhibitors
IT1393351B1 (it) 2009-03-16 2012-04-20 Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi

Also Published As

Publication number Publication date
US20120010415A1 (en) 2012-01-12
CN106187882A (zh) 2016-12-07
US8642767B2 (en) 2014-02-04
EP2641897A3 (en) 2013-11-20
SMT201600356B (it) 2016-11-10
HK1167136A1 (en) 2012-11-23
CN102356063B (zh) 2014-09-24
EP3103792A1 (en) 2016-12-14
HRP20161163T1 (hr) 2016-11-04
DK2408739T3 (da) 2013-11-04
HK1205105A1 (en) 2015-12-11
JP6061158B2 (ja) 2017-01-18
IT1393351B1 (it) 2012-04-20
EP2408739B1 (en) 2013-08-14
WO2010105761A1 (en) 2010-09-23
CY1114503T1 (el) 2016-10-05
PT2408739E (pt) 2013-10-21
EP2641897A2 (en) 2013-09-25
US9340508B2 (en) 2016-05-17
PL2641897T3 (pl) 2017-01-31
CN104193676A8 (zh) 2016-08-17
SI2641897T1 (sl) 2016-10-28
JP2015180665A (ja) 2015-10-15
PT2641897T (pt) 2016-08-04
SI2408739T1 (sl) 2013-11-29
JP5817079B2 (ja) 2015-11-18
EP2408739A1 (en) 2012-01-25
HUE029528T2 (en) 2017-03-28
ITMI20090397A1 (it) 2010-09-17
ES2585221T3 (es) 2016-10-04
ES2431618T3 (es) 2013-11-27
JP2012520332A (ja) 2012-09-06
US20150191429A1 (en) 2015-07-09
HRP20130978T1 (hr) 2013-11-22
CN104193676B (zh) 2016-08-17
PL2408739T3 (pl) 2014-01-31
CY1117871T1 (el) 2017-05-17
CN102356063A (zh) 2012-02-15
US20140114075A1 (en) 2014-04-24
CN104193676A (zh) 2014-12-10
US9012645B2 (en) 2015-04-21
EP2641897B1 (en) 2016-07-13

Similar Documents

Publication Publication Date Title
DK2641897T3 (da) Fremgangsmåde til fremstilling af 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamid og syntetiske mellemprodukter deraf
EP3045461A1 (en) Processes for preparing dolutegravir and analogues thereof
US10040793B2 (en) Key intermediates and impurities of the synthesis of Apixaban: Apixaban glycol esters
KR102671396B1 (ko) 프로테인 카이네이즈에 대한 선택적 억제제의 합성에 유용한 중간체 및 이의 제조방법
US10099981B2 (en) Methods for meta-arylation of aromatic alcohols
KR100720220B1 (ko) 치환 아닐린 화합물의 제조방법
KR20180116371A (ko) 4-알콕시-3-히드록시피콜린산의 제조 방법
US20090221828A1 (en) Process for Preparing 1-Halo-2,7-Naphthyridinyl Derivatives
US8093384B2 (en) Processes for the preparation of alfuzosin
US9115130B2 (en) Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives
Rahimizadeh et al. Vicarious nucleophilic substitution in nitro derivatives of imidazo [1, 2-a] pyridine
HRP20020471A2 (en) Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
JPH02289563A (ja) o―カルボキシピリジル―およびo―カルボキシキノリルイミダゾリノンの改良製造法
EP3710445B1 (en) Process for the preparation of raltegravir
KR102188341B1 (ko) 아픽사반의 제조방법
EP3510031B1 (en) Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole
KR20240038024A (ko) B형 간염 바이러스 뉴클레오캡시드 억제제의 제조 방법
CZ288287B6 (en) Process for preparing 5-(alkoxymethyl)-2,3-pyridine dicarboximide compounds
NZ237143A (en) Process for preparing uracil derivatives
WO2007117009A1 (ja) 2,2-ジアルコキシエチルアミン化合物およびその製造方法
KR20020030786A (ko) 치환 벤즈이소티아졸 화합물의 제조 방법